SBH
EBS icon

Segall Bryant & Hamill’s Emergent Biosolutions EBS Stock Holding History

Segall Bryant & Hamill’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$798K Sell
95,205
-10,775
-10% -$90.2K 0.01% 554
2026
Q1 		$880K Hold
105,980
– – 0.01% 521
2025
Q4 		$1.31M Buy
105,980
+25,131
+31% +$269K 0.02% 481
2025
Q3 		$713K Buy
+80,849
New +$629K 0.01% 524
2016
Q4 		– Sell
-18,349
Closed -$579K – 545
2016
Q3 		$579K Buy
18,349
+78
+0.4% +$2.27K 0.01% 390
2016
Q2 		$514K Buy
18,271
+1,185
+7% +$46.5K 0.01% 412
2016
Q1 		$621K Buy
17,086
+3,950
+30% +$140K 0.02% 392
2015
Q4 		$526K Sell
13,136
-15
-0.1% -$523 0.01% 402
2015
Q3 		$375K Sell
13,151
-7,121
-35% -$235K 0.01% 449
2015
Q2 		$668K Sell
20,272
-124,386
-86% -$3.86M 0.02% 386
2015
Q1 		$4.16M Sell
144,658
-198,444
-58% -$5.69M 0.09% 238
2014
Q4 		$9.34M Buy
343,102
+43,022
+14% +$1.03M 0.21% 148
2014
Q3 		$6.39M Buy
300,080
+132,244
+79% +$3.03M 0.15% 178
2014
Q2 		$3.77M Sell
167,836
-17,395
-9% -$405K 0.09% 217
2014
Q1 		$4.68M Sell
185,231
-485
-0.3% -$12.3K 0.11% 205
2013
Q4 		$4.27M Sell
185,716
-5,595
-3% -$117K 0.1% 210
2013
Q3 		$3.64M Buy
191,311
+8,236
+4% +$147K 0.09% 219
2013
Q2 		$2.64M Buy
+183,075
New +$2.65M 0.07% 241

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Segall Bryant & Hamill's EBS Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its Emergent Biosolutions (EBS) stake by 10% in Q2 2026, selling an estimated $90.2K and leaving 95,205 shares worth $798K. The position accounts for 0.01% of the portfolio, ranked #554.

Segall Bryant & Hamill first reported a position in EBS in Q2 2013 and has held it in 18 quarters since. The position peaked at $9.34M in Q4 2014. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Segall Bryant & Hamill held 95,205 shares of Emergent Biosolutions worth $798K as of Q2 2026.
  • Segall Bryant & Hamill sold 10,775 Emergent Biosolutions shares in Q2 2026, an estimated $90.2K.
  • Emergent Biosolutions made up 0.01% of Segall Bryant & Hamill's portfolio in Q2 2026, its #554 holding.
  • Segall Bryant & Hamill first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 18 quarters since.
  • Segall Bryant & Hamill's Emergent Biosolutions position peaked at $9.34M in Q4 2014.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.